摘要
目的探讨血清胆碱酯酶(CHE)活性测定在结肠癌诊断中的价值。方法采用速率法检测56例经肠镜活检或外科手术病理证实的结肠癌患者(其中男性30例,女性26例)血清中胆碱酯酶的含量,并与40例正常对照者比较,对结果进行分析。结果30例男性结肠癌患者血清CHE含量为4015.52±818.87U/L,正常组为7877.90±1769.38U/L,两者差异显著(P<0.01);26例女性患者血清CHE含量为3879.03±715.34U/L,正常组为6384.90±1315.37U/L,两者差异显著(P<0.01)。结论血清CHE活性测定可作为诊断结肠癌的标志物,对结肠癌患者的筛查和诊断具有重要的临床意义。
Objective To study the applied value by measuring the activities of serum eholinesterase（CHE） on diagnosis to segmented intestine cancer. Methods 56 serum samples of patients with segmented intestine cancer certificated by endoscopic biopsy and surgical pathology and 40 serum samples of the healthy were detected for the level of CHE. Results In male patients, the level of CHE was 4015.52±818.87U/L; in female patients, the CHE was 3879.03±715.34U/L In comparison with the control, the difference was significant（P〈 0.01）. Conclusions As the marker of segmented intestine cancer, the CHE has significantly clinical value on screening and diagnosis to segmented intestine cancer.
出处
《海南医学》
CAS
2006年第5期164-165,共2页
Hainan Medical Journal
关键词
胆碱酯酶
结肠癌
eholinesterase
segmented intestine cancer
